Works matching AU Lassen, Ulrik

Results: 91

Twenty-one-year report from the Danish Health Authority Expert Advisory Panel for review of treatment of 10 000 cancer patients.

Published in:

Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf059

By:

Ladekarl, Morten;
Mørk, Mette Louise;
Albertsen, Emma Skotte;
Nielsen, Dorte;
Lassen, Ulrik;
Mau-Sørensen, Morten;
Nielsen, Claus Malta;
Jakobsen, Anders;
von der Maase, Hans

Publication type:

Article

Detecting and Targeting NTRK Fusions in Cancer in the Era of Tumor Agnostic Oncology.

Published in:

Drugs, 2021, v. 81, n. 4, p. 445, doi. 10.1007/s40265-020-01459-w

By:

Rohrberg, Kristoffer S.;
Lassen, Ulrik

Publication type:

Article

TRK Inhibition: A New Tumor-Agnostic Treatment Strategy.

Published in:

2018

By:

Kummar, Shivaani;
Lassen, Ulrik N.

Publication type:

journal article

First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors.

Published in:

2016

By:

Dienstmann, Rodrigo;
Lassen, Ulrik;
Cebon, Jonathan;
Desai, Jayesh;
Brown, Michael;
Evers, Stefan;
Su, Fei;
Zhang, Weijiang;
Boisserie, Frederic;
Lestini, Brian;
Schostack, Kathleen;
Meresse, Valerie;
Tabernero, Josep;
Brown, Michael P

Publication type:

journal article

Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction

Published in:

European Journal of Heart Failure, 2005, v. 7, n. 1, p. 87, doi. 10.1016/j.ejheart.2004.03.009

By:

Daugaard, Gedske;
Lassen, Ulrik;
Bie, Peter;
Pedersen, Erling Bjerregaard;
Jensen, Kaare Troels;
Abildgaard, Ulrik;
Hesse, Birger;
Kjaer, Andreas

Publication type:

Article

Extracranial metastases in glioblastoma—Two case stories.

Published in:

Clinical Case Reports, 2019, v. 7, n. 2, p. 289, doi. 10.1002/ccr3.1980

By:

Schou Nørøxe, Dorte;
Regner Michaelsen, Signe;
Broholm, Helle;
Møller, Søren;
Skovgaard Poulsen, Hans;
Lassen, Ulrik

Publication type:

Article

Actionable alterations in glioblastoma: Insights from the implementation of genomic profiling as the standard of care from 2016 to 2023.

Published in:

Neuro-Oncology Practice, 2025, v. 12, n. 1, p. 34, doi. 10.1093/nop/npae082

By:

Fougner, Vincent;
Urup, Thomas;
Poulsen, Hans Skovgaard;
Grunnet, Kirsten;
Westmose, Christina Yde;
Melchior, Linea Cecilie;
Larsen, Karen Bonde;
Højgaard, Martin;
Spanggaard, Iben;
Belcaid, Laila;
Rohrberg, Kristoffer Staal;
Lassen, Ulrik;
Hasselbalch, Benedikte;
Nørøxe, Dorte Schou

Publication type:

Article

Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein.

Published in:

Cells (2073-4409), 2019, v. 8, n. 9, p. 998, doi. 10.3390/cells8090998

By:

Bang-Christensen, Sara R.;
Pedersen, Rasmus S.;
Pereira, Marina A.;
Clausen, Thomas M.;
Løppke, Caroline;
Sand, Nicolai T.;
Ahrens, Theresa D.;
Jørgensen, Amalie M.;
Lim, Yi Chieh;
Goksøyr, Louise;
Choudhary, Swati;
Gustavsson, Tobias;
Dagil, Robert;
Daugaard, Mads;
Sander, Adam F.;
Torp, Mathias H.;
Søgaard, Max;
Theander, Thor G.;
Østrup, Olga;
Lassen, Ulrik

Publication type:

Article

IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition.

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1360281

By:

Borch, Annie;
Carri, Ibel;
Reynisson, Birkir;
Alvarez, Heli M. Garcia;
Munk, Kamilla K.;
Montemurro, Alessandro;
Kristensen, Nikolaj Pagh;
Tvingsholm, Siri A.;
Holm, Jeppe Sejerø;
Heeke, Christina;
Moss, Keith Henry;
Hansen, Ulla Kring;
Schaap-Johansen, Anna-Lisa;
Bagger, Frederik Otzen;
de Lima, Vinicius Araujo Barbosa;
Rohrberg, Kristoffer S.;
Funt, Samuel A.;
Donia, Marco;
Svane, Inge Marie;
Lassen, Ulrik

Publication type:

Article

Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy.

Published in:

Frontiers in Genetics, 2023, v. 14, p. 1, doi. 10.3389/fgene.2023.1058605

By:

Borch, Annie;
Bjerregaard, Anne-Mette;
Barbosa de Lima, Vinicius Araujo;
Østrup, Olga;
Yde, Christina Westmose;
Eklund, Aron Charles;
Mau-Sørensen, Morten;
Barra, Carolina;
Svane, Inge Marie;
Nielsen, Finn Cilius;
Funt, Samuel A.;
Lassen, Ulrik;
Hadrup, Sine Reker

Publication type:

Article

PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.

Published in:

Acta Oncologica, 2024, v. 63, p. 385, doi. 10.2340/1651-226X.2024.34791

By:

Taskéna, Kjetil;
Haj Mohammad, Soemeya F.;
Fagereng, Gro Live;
Sørum Falk, Ragnhild;
Helland, Åslaug;
van Doorn-Khosrovani, Sahar Barjesteh van Waalwijk;
Steen Carlsson, Katarina;
Ryll, Bettina;
Jalkanen, Katriina;
Edsjö, Anders;
Russnes, Hege G.;
Lassen, Ulrik;
Hallersjö Hult, Ebba Hallersjö;
Lugowska, Iwona;
Blay, Jean-Yves;
Verlingue, Loic;
Abel, Edvard;
Lowery, Maeve A.;
Krebs, Matthew G.;
Rohrberg, Kristoffer Staal

Publication type:

Article

PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe.

Published in:

Acta Oncologica, 2024, v. 63, n. 1, p. 384, doi. 10.2340/1651-226X.2024.34791

By:

Taskén, Kjetil;
Mohammad, Soemeya F. Haj;
Fagereng, Gro Live;
Falk, Ragnhild Sørum;
Helland, Åslaug;
van Doorn-Khosrovani, Sahar Barjesteh van Waalwijk;
Carlsson, Katarina Steen;
Ryll, Bettina;
Jalkanen, Katriina;
Edsjö, Anders;
Russnes, Hege G.;
Lassen, Ulrik;
Hult, Ebba Hallersjö;
Lugowska, Iwona;
Blay, Jean-Yves;
Verlingue, Loic;
Abel, Edvard;
Lowery, Maeve A.;
Krebs, Matthew G.;
Rohrberg, Kristoffer Staal

Publication type:

Article

Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005–2017.

Published in:

Acta Oncologica, 2023, v. 62, n. 12, p. 1653, doi. 10.1080/0284186X.2023.2270145

By:

Thomsen, Mette K.;
Løppenthin, Katrine B.;
Bidstrup, Pernille E.;
Andersen, Elisabeth W.;
Dalton, Susanne;
Petersen, Lone N.;
Pappot, Helle;
Mortensen, Christiane E.;
Christensen, Mikkel B.;
Frølich, Anne;
Lassen, Ulrik;
Johansen, Christoffer

Publication type:

Article

Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact.

Published in:

Acta Oncologica, 2022, v. 61, n. 12, p. 1499, doi. 10.1080/0284186X.2022.2156809

By:

Jacobsen, Ida Christine;
Spanggaard, Iben;
Højgaard, Martin;
Belcaid, Laïla;
Qvortrup, Camilla;
Yde, Christina Westmose;
Schmidt, Ane Yde;
Nielsen, Finn Cilius;
Willemoe, Gro Linno;
Dam, Mikkel Seidelin;
Lassen, Ulrik;
Staal Rohrberg, Kristoffer

Publication type:

Article

Late effects – the new focus of follow-up.

Published in:

2022

By:

Johansen, Christoffer;
von Heymann, Annika;
Rafn, Bolette S.;
Borgquist, Signe;
Christiansen, Peer;
Christensen, Peter;
Zachariae, Robert;
Pappot, Helle;
Lassen, Ulrik

Publication type:

Editorial

Patients in phase 1 cancer trials: psychological distress and understanding of trial information.

Published in:

Acta Oncologica, 2022, v. 61, n. 3, p. 341, doi. 10.1080/0284186X.2021.1993331

By:

Gad, Katrine T.;
Lassen, Ulrik;
Duun-Henriksen, Anne K.;
Dalton, Susanne O.;
Mau-Sørensen, Morten;
Bidstrup, Pernille E.;
Høeg, Beverley. L.;
Rohrberg, Kristoffer S.;
Spanggard, Iben;
von Heymann, Annika;
Johansen, Christoffer

Publication type:

Article

A systematic review of targeted agents for non-small cell lung cancer.

Published in:

Acta Oncologica, 2018, v. 57, n. 2, p. 176, doi. 10.1080/0284186X.2017.1404634

By:

Vestergaard, Hannah H.;
Christensen, Marcus R.;
Lassen, Ulrik N.

Publication type:

Article

Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan.

Published in:

Acta Oncologica, 2016, v. 55, n. 4, p. 418, doi. 10.3109/0284186X.2015.1114679

By:

Urup, Thomas;
Dahlrot, Rikke Hedegaard;
Grunnet, Kirsten;
Christensen, Ib Jarle;
Michaelsen, Signe Regner;
Toft, Anders;
Larsen, Vibeke Andrée;
Broholm, Helle;
Kosteljanetz, Michael;
Hansen, Steinbjørn;
Poulsen, Hans Skovgaard;
Lassen, Ulrik

Publication type:

Article

Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.

Published in:

Acta Oncologica, 2014, v. 53, n. 7, p. 939, doi. 10.3109/0284186X.2013.879607

By:

Hofland, Kenneth F.;
Hansen, Steinbjørn;
Sorensen, Morten;
Engelholm, Silke;
Schultz, Henrik P.;
Muhic, Aida;
Grunnet, Kirsten;
Ask, Anders;
Costa, Junia C.;
Kristiansen, Charlotte;
Thomsen, Carsten;
Poulsen, Hans Skovgaard;
Lassen, Ulrik

Publication type:

Article

Phase II trial of temsirolimus alone and in combination with irinotecan for KRAS mutant metastatic colorectal cancer: Outcome and results of KRAS mutational analysis in plasma.

Published in:

Acta Oncologica, 2013, v. 52, n. 5, p. 963, doi. 10.3109/0284186X.2013.776175

By:

Spindler, Karen-Lise G.;
Sorensen, Morten M.;
Pallisgaard, Niels;
Andersen, Rikke F.;
Havelund, Birgitte M.;
Ploen, John;
Lassen, Ulrik;
Jakobsen, Anders K. M.

Publication type:

Article

A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy.

Published in:

Acta Oncologica, 2012, v. 51, n. 6, p. 797, doi. 10.3109/0284186X.2012.681063

By:

Møller, Søren;
Grunnet, Kirsten;
Hansen, Steinbjørn;
Schultz, Henrik;
Holmberg, Mats;
Sorensen, Morten;
Poulsen, Hans S.;
Lassen, Ulrik

Publication type:

Article

Phase II trial of erlotinib and bevacizumab in patients with advanced upper gastrointestinal cancers.

Published in:

Acta Oncologica, 2012, v. 51, n. 2, p. 234, doi. 10.3109/0284186X.2011.619568

By:

Rohrberg, Kristoffer S.;
Olesen, René K.;
Pfeiffer, Per;
Ladekarl, Morten;
Pappot, Helle;
Christensen, Ib J.;
Høyer-Hansen, Gunilla;
Sørensen, Morten;
Skov, Birgit G.;
Buysschaert, Ian;
Carmeliet, Peter;
Lassen, Ulrik

Publication type:

Article

A Phase I--II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas.

Published in:

Acta Oncologica, 2011, v. 50, n. 3, p. 448, doi. 10.3109/0284186X.2010.500300

By:

Lassen, Ulrik;
Jensen, Lars Henrik;
Sorensen, Morten;
Rohrberg, Kristoffer S.;
Ujmajuridze, Zaza;
Jakobsen, Anders

Publication type:

Article

Bevacizumab plus irinotecan in the treatment patients with progressive recurrent malignant brain tumours.

Published in:

Acta Oncologica, 2009, v. 48, n. 1, p. 52, doi. 10.1080/02841860802537924

By:

Poulsen, Hans Skovgaard;
Grunnet, Kirsten;
Sorensen, Morten;
Olsen, Preben;
Hasselbalch, Benedikte;
Nelausen, Knud;
Kosteljanetz, Michael;
Lassen, Ulrik

Publication type:

Article

18F-FET MicroPET and MicroMRI for Anti-VEGF and Anti-PlGF Response Assessment in an Orthotopic Murine Model of Human Glioblastoma.

Published in:

PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0115315

By:

Nedergaard, Mette Kjoelhede;
Michaelsen, Signe Regner;
Urup, Thomas;
Broholm, Helle;
El Ali, Henrik;
Poulsen, Hans Skovgaard;
Stockhausen, Marie-Thérése;
Kjaer, Andreas;
Lassen, Ulrik

Publication type:

Article

The Use of Longitudinal 18F-FET MicroPET Imaging to Evaluate Response to Irinotecan in Orthotopic Human Glioblastoma Multiforme Xenografts.

Published in:

PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0100009

By:

Nedergaard, Mette K.;
Kristoffersen, Karina;
Michaelsen, Signe R.;
Madsen, Jacob;
Poulsen, Hans S.;
Stockhausen, Marie-Thérése;
Lassen, Ulrik;
Kjaer, Andreas

Publication type:

Article

Degradation fragments of Tau and type IV collagen as serum biomarkers in patients with recurrent glioblastoma treated with nivolumab and bevacizumab.

Published in:

Clinical & Translational Oncology, 2025, v. 27, n. 6, p. 2761, doi. 10.1007/s12094-024-03775-z

By:

Jensen, Christina;
Maarup, Simone;
Poulsen, Hans Skovgaard;
Hasselbalch, Benedikte;
Karsdal, Morten;
Svane, Inge Marie;
Lassen, Ulrik;
Willumsen, Nicholas

Publication type:

Article

Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study.

Published in:

Oncology, 2022, v. 100, n. 2, p. 124, doi. 10.1159/000519767

By:

Briggs, Andrew;
Paracha, Noman;
Rosettie, Katherine;
Upton, Alexander;
Bokemeyer, Carsten;
Lassen, Ulrik;
Sullivan, Sean D.

Publication type:

Article

Magnetic resonance imaging and o-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography for early response assessment of nivolumab and bevacizumab in patients with recurrent high-grade astrocytic glioma.

Published in:

Neuro-Oncology Advances, 2024, v. 6, n. 1, p. 1, doi. 10.1093/noajnl/vdae178

By:

Henriksen, Otto Mølby;
Maarup, Simone;
Hasselbalch, Benedikte;
Poulsen, Hans Skovgaard;
Christensen, Ib Jarle;
Madsen, Karine;
Larsen, Vibeke Andrée;
Lassen, Ulrik;
Law, Ian

Publication type:

Article

The Neurogenome study: Comprehensive molecular profiling to optimize treatment for Danish glioblastoma patients.

Published in:

Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad137

By:

Nørøxe, Dorte Schou;
Maarup, Simone;
Fougner, Vincent;
Muhic, Aida;
Møller, Søren;
Urup, Thomas;
Lü, Maya Jeje Schuang;
Weischenfeldt, Joachim;
Hansen, Adam Espe;
Poulsen, Hans Skovgaard;
Lassen, Ulrik;
Hasselbalch, Benedikte

Publication type:

Article

Implementing targeted therapies in the treatment of glioblastoma: Previous shortcomings, future promises, and a multimodal strategy recommendation.

Published in:

Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac157

By:

Benedikte Hasselbalch, Vincent Fougner;
Lassen, Ulrik;
Weischenfeldt, Joachim;
Poulsen, Hans Skovgaard;
Urup, Thomas

Publication type:

Article

Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor (Adv. Healthcare Mater. 1/2022).

Published in:

Advanced Healthcare Materials, 2022, v. 11, n. 1, p. 1, doi. 10.1002/adhm.202270001

By:

Rafaeva, Maria;
Horton, Edward R.;
Jensen, Adina R.D.;
Madsen, Chris D.;
Reuten, Raphael;
Willacy, Oliver;
Brøchner, Christian B.;
Jensen, Thomas H.;
Zornhagen, Kamilla Westarp;
Crespo, Marina;
Grønseth, Dina S.;
Nielsen, Sebastian R.;
Idorn, Manja;
Straten, Per thor;
Rohrberg, Kristoffer;
Spanggaard, Iben;
Højgaard, Martin;
Lassen, Ulrik;
Erler, Janine T.;
Mayorca‐Guiliani, Alejandro E.

Publication type:

Article

Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor.

Published in:

Advanced Healthcare Materials, 2022, v. 11, n. 1, p. 1, doi. 10.1002/adhm.202100684

By:

Rafaeva, Maria;
Horton, Edward R.;
Jensen, Adina R.D.;
Madsen, Chris D.;
Reuten, Raphael;
Willacy, Oliver;
Brøchner, Christian B.;
Jensen, Thomas H.;
Zornhagen, Kamilla Westarp;
Crespo, Marina;
Grønseth, Dina S.;
Nielsen, Sebastian R.;
Idorn, Manja;
Straten, Per thor;
Rohrberg, Kristoffer;
Spanggaard, Iben;
Højgaard, Martin;
Lassen, Ulrik;
Erler, Janine T.;
Mayorca‐Guiliani, Alejandro E.

Publication type:

Article

Effect of bevacizumab on intracranial meningiomas in patients with neurofibromatosis type 2 – a retrospective case series.

Published in:

International Journal of Neuroscience, 2016, v. 126, n. 11, p. 1002, doi. 10.3109/00207454.2015.1092443

By:

Alanin, Mikkel Christian;
Klausen, Camilla;
Caye-Thomasen, Per;
Thomsen, Carsten;
Fugleholm, Kaare;
Poulsgaard, Lars;
Lassen, Ulrik;
Mau-Sorensen, Morten;
Hofland, Kenneth Francis

Publication type:

Article

Concordance of Mutation Detection in Circulating Tumor DNA in Early Clinical Trials Using Different Blood Collection Protocols.

Published in:

Clinical Laboratory, 2017, n. 10, p. 1755, doi. 10.7754/Clin.Lab.2017.170516

By:

Ahlborn, Lise B.;
Madsen, Mette;
Jønson, Lars;
Nielsen, Finn C.;
Lassen, Ulrik;
Yde, Christina W.;
Mau-Sørensen, Morten

Publication type:

Article

Biomarkers in tissue from patients with upper gastrointestinal cancers treated with erlotinib and bevacizumab.

Published in:

Cancer Biology & Therapy, 2011, v. 11, n. 8, p. 732, doi. 10.4161/cbt.11.8.14889

By:

Rohrberg, Kristoffer Staal;
Pappot, Helle;
Lassen, Ulrik;
Westman, Maj;
Olesen, René K.;
Pfeiffer, Per;
Ladekarl, Morten;
Sørensen, Morten;
Christensen, Ib J.;
Skov, Birgit G.

Publication type:

Article

Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.

Published in:

2019

By:

Dombernowsky, Tilde;
Haedersdal, Merete;
Lassen, Ulrik;
Thomsen, Simon Francis

Publication type:

journal article

ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling – a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial.

Published in:

BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10632-9

By:

Kringelbach, Tina;
Højgaard, Martin;
Rohrberg, Kristoffer;
Spanggaard, Iben;
Laursen, Britt Elmedal;
Ladekarl, Morten;
Haslund, Charlotte Aaquist;
Harsløf, Laurine;
Belcaid, Laila;
Gehl, Julie;
Søndergaard, Lise;
Eefsen, Rikke Løvendahl;
Hansen, Karin Holmskov;
Kodahl, Annette Raskov;
Jensen, Lars Henrik;
Holt, Marianne Ingerslev;
Oellegaard, Trine Heide;
Yde, Christina Westmose;
Ahlborn, Lise Barlebo;
Lassen, Ulrik

Publication type:

Article

A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24.

Published in:

2019

By:

Mirza, Mansoor Raza;
Bergmann, Troels K.;
Mau-Sørensen, Morten;
Christensen, René dePont;
Åvall-Lundqvist, Elisabeth;
Birrer, Michael J.;
Jørgensen, Morten;
Roed, Henrik;
Malander, Susanne;
Nielsen, Flemming;
Lassen, Ulrik;
Brøsen, Kim;
Bjørge, Line;
Mäenpää, Johanna

Publication type:

journal article

A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors.

Published in:

2018

By:

de Weger, Vincent A.;
Goel, Sanjay;
von Moos, Roger;
Schellens, Jan H. M.;
Mach, Nicholas;
Tan, Eugene;
Anand, Suraj;
Scott, Jeffrey W.;
Lassen, Ulrik

Publication type:

journal article

A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3.

Published in:

Cancer Chemotherapy & Pharmacology, 2015, v. 75, n. 5, p. 1065, doi. 10.1007/s00280-015-2728-5

By:

Mau-Sørensen, Morten;
Dittrich, Christian;
Dienstmann, Rodrigo;
Lassen, Ulrik;
Büchler, Wilfried;
Martinius, Holger;
Tabernero, Josep

Publication type:

Article

Characteristics of de novo cancer in liver transplant recipients.

Published in:

APMIS, 2023, v. 131, n. 4, p. 135, doi. 10.1111/apm.13296

By:

Riis, Tine Holm;
Møller, Dina Leth;
Høgh, Julie;
Knudsen, Andreas Dehlbæk;
Rostved, Andreas Arendtsen;
Akdag, Delal;
Kirkby, Nikolai;
Lassen, Ulrik;
Rasmussen, Allan;
Hillingsø, Jens G.;
Pommergaard, Hans‐Christian

Publication type:

Article

Personalized oncology: genomic screening in phase 1.

Published in:

APMIS, 2014, v. 122, n. 8, p. 723, doi. 10.1111/apm.12293

By:

Tuxen, Ida Viller;
Jønson, Lars;
Santoni-Rugiu, Eric;
Hasselby, Jane Preuss;
Nielsen, Finn Cilius;
Lassen, Ulrik

Publication type:

Article

Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2 -expressing normal lung.

Published in:

Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221133893

By:

Lazar, Vladimir;
Raynaud, Jacques;
Magidi, Shai;
Bresson, Catherine;
Martini, Jean-François;
Galbraith, Susan;
Wunder, Fanny;
Onn, Amir;
Batist, Gerald;
Girard, Nicolas;
Lassen, Ulrik;
Pramesh, C. S.;
Al-Omari, Amal;
Ikeda, Sadakatsu;
Berchem, Guy;
Blay, Jean-Yves;
Solomon, Benjamin;
Felip, Enriqueta;
Tabernero, Josep;
Rubin, Eitan

Publication type:

Article

Urokinase-Type Plasminogen Activator Receptor as a Potential PET Biomarker in Glioblastoma.

Published in:

Journal of Nuclear Medicine, 2016, v. 57, n. 2, p. 272, doi. 10.2967/jnumed.115.161703

By:

Persson, Morten;
Nedergaard, Mette K.;
Brandt-Larsen, Malene;
Skovgaard, Dorthe;
Jørgensen, Jesper T.;
Michaelsen, Signe R.;
Madsen, Jacob;
Lassen, Ulrik;
Poulsen, Hans S.;
Kjaer, Andreas

Publication type:

Article

Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.

Published in:

Journal of Neuro-Oncology, 2018, v. 137, n. 3, p. 533, doi. 10.1007/s11060-017-2739-7

By:

Michaelsen, Signe Regner;
Urup, Thomas;
Olsen, Lars Rønn;
Broholm, Helle;
Lassen, Ulrik;
Poulsen, Hans Skovgaard

Publication type:

Article

Phase II open-label study of nintedanib in patients with recurrent glioblastoma multiforme.

Published in:

Journal of Neuro-Oncology, 2013, v. 111, n. 2, p. 205, doi. 10.1007/s11060-012-1009-y

By:

Muhic, Aida;
Poulsen, Hans;
Sorensen, Morten;
Grunnet, Kirsten;
Lassen, Ulrik

Publication type:

Article

Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 5, p. 802, doi. 10.1007/s00259-010-1703-y

By:

Søgaard, Rikke;
Fischer, Barbara;
Mortensen, Jann;
Højgaard, Liselotte;
Lassen, Ulrik

Publication type:

Article

High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer.

Published in:

NPJ Genomic Medicine, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41525-019-0087-6

By:

Bertelsen, Birgitte;
Tuxen, Ida Viller;
Yde, Christina Westmose;
Gabrielaite, Migle;
Torp, Mathias Husted;
Kinalis, Savvas;
Oestrup, Olga;
Rohrberg, Kristoffer;
Spangaard, Iben;
Santoni-Rugiu, Eric;
Wadt, Karin;
Mau-Sorensen, Morten;
Lassen, Ulrik;
Nielsen, Finn Cilius

Publication type:

Article

Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan.

Published in:

APMIS, 2010, v. 118, n. 8, p. 585, doi. 10.1111/j.1600-0463.2010.02631.x

By:

HASSELBALCH, BENEDIKTE;
ERIKSEN, JESPER GRAU;
BROHOLM, HELLE;
CHRISTENSEN, IB JARLE;
GRUNNET, KIRSTEN;
HORSMAN, MICHAEL R.;
POULSEN, HANS SKOVGAARD;
STOCKHAUSEN, MARIE-THÉRÉSE;
LASSEN, ULRIK

Publication type:

Article